✦ LIBER ✦

P.3.d.001 In-vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors

✍ Scribed by Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.d.002 Characterization of aripiprazo

✍ Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Functional potencies of dopamine agonist

✍ Yoshihiro Tadori; Robert A. Forbes; Robert D. McQuade; Tetsuro Kikuchi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 625 KB

Aripiprazole and its human metabolite ar

✍ Martyn D. Wood; Claire Scott; Kirsten Clarke; Julie Westaway; Ceri H. Davies; Ch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Intrinsic Efficacy of Antipsychotics at

✍ Burstein, E. S. 📂 Article 📅 2005 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 576 KB

3-PPP antagonizes the in vitro effects o

✍ Johan F. Plantjé; Arie H. Mulder; Johannes C. Stoof 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Dopamine agonists used in the treatment

✍ Jacques De Keyser; Jean-Paul De Backer; Nadine Wilczak; Luc Herroelen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 539 KB